Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The epidemiology of ecstasy use and harms in Australia.
Degenhardt L, Roxburgh A, Dunn M, Campbell G, Bruno R, Kinner SA, George J, Quinn B, White N, Topp L. Degenhardt L, et al. Among authors: white n. Neuropsychobiology. 2009;60(3-4):176-87. doi: 10.1159/000253553. Epub 2009 Nov 5. Neuropsychobiology. 2009. PMID: 19893334
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film.
White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. White N, et al. Drug Alcohol Rev. 2016 Jan;35(1):76-82. doi: 10.1111/dar.12317. Epub 2015 Sep 1. Drug Alcohol Rev. 2016. PMID: 26331899
DESIGN AND METHODS: Mixed methods study drawing on: (i) structured interviews with current OST clients (n = 60) who reported being incarcerated in the 12 months prior to being interviewed and (ii) qualitative interviews with key experts working in corrections and prison (o …
DESIGN AND METHODS: Mixed methods study drawing on: (i) structured interviews with current OST clients (n = 60) who reported being in …
Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia.
Larance B, Mattick R, Ali R, Lintzeris N, Jenkinson R, White N, Kihas I, Cassidy R, Degenhardt L. Larance B, et al. Among authors: white n. Drug Alcohol Rev. 2016 Jan;35(1):83-91. doi: 10.1111/dar.12344. Epub 2015 Oct 9. Drug Alcohol Rev. 2016. PMID: 26450513
DESIGN AND METHODS: Interviews were conducted with people who inject drugs regularly (PWID) (2004-2013), opioid substitution therapy clients (2013, n = 492) and key experts (n = 44). Key outcomes were unsanctioned removal of supervised doses, diversion, injection an …
DESIGN AND METHODS: Interviews were conducted with people who inject drugs regularly (PWID) (2004-2013), opioid substitution therapy clients …
3,408 results